Apr 21 2012
Health Discovery Corporation (OTCBB: HDVY), the molecular diagnostics
company that launched MelApp, the first SVM-based image analysis iPhone
app for melanoma risk assessment is featured in this month's Men's
Health Magazine.
First launched last summer for iPhone, MelApp uses highly sophisticated
patent protected mathematical algorithms and image based pattern
recognition technology to analyze an uploaded image. The app was
validated using an image database licensed from Johns Hopkins University
Medical Center and uses a device's camera feature to deliver a risk
analysis of user's photographed skin lesions within seconds. In
addition, MelApp can use the smartphone's GPS to refer users to
physicians specializing in the diagnosis and treatment of melanoma for
proper medical diagnosis and treatment.
"Being currently used in nearly 50 countries, and having been named one
of the 'Top 10 Apps That Could Save Your Life' in a recent
issue of Parade Magazine, MelApp has become a worldwide success," stated
Stephen D. Barnhill, M.D. Chairman and CEO of Health Discovery
Corporation. "We are very proud of the fact that we continue to hear
from people who have used MelApp and as a result they have made
appointments with their physicians to have a proper medical examination
and biopsy which led to a diagnosis of early melanoma still in the
curable stage. This demonstrates the importance of MelApp in educating
the public about melanoma."
Source: Health Discovery Corporation
Long-term survival achieved in stage III melanoma with pre-surgery immunotherapy